Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trial

The Lancet. Infectious diseases(2023)

引用 5|浏览11
暂无评分
摘要
The US Centers for Disease Control and Prevention.
更多
查看译文
关键词
bivalent oral poliovirus vaccine,immunogenicity,open-label,non-inferiority
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要